In terms of regulation of CD4+ T cells, JKAP is reported to repress CD4+ T‐cell activation as well as its differentiation into Th1 and Th17 cells in systemic lupus erythematosus nephritis and inflammatory bowel disease.12, 13. This evidence concerns the gene CD4 and inflammatory bowel disease.